Bowel (colorectal) cancer, Breast cancer, Cervical cancer, Head and neck cancers, Kidney cancer, Lung cancer, Non small cell lung cancer (NSCLC), Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Renal cell cancer, Secondary cancers
Open
Phase 1/2
This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for that have spread ().
It is open to people whose treatment has stopped working and there is no standard treatment available.
Recruitment start: 9 July 2024
Recruitment end: 28 February 2029
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Fiona Thistlewaite
Cancer Research UK
Centre for Drug Development
UCB Biopharma SRL
This is Cancer Research UK trial number CRUKD/24/001.
Last reviewed: 24 Sept 2025
CRUK internal database number: 19883
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
